Butterfly Needles Market
Report ID: SQMIG35A3254
Report ID: SQMIG35A3254
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A3254 |
Region:
Global |
Published Date: March, 2026
Pages:
157
|Tables:
114
|Figures:
77
Global Butterfly Needles Market size was valued at USD 1.3 Billion in 2024 and is poised to grow from USD 1.41 Billion in 2025 to USD 2.75 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).
The butterfly needle market comprises winged infusion sets used for venous access in phlebotomy, infusion and blood collection, and it matters because these devices shape patient comfort, sampling reliability and safety across hospitals, diagnostic labs and home care. The primary driver is rising demand for minimally invasive, safety-engineered devices as aging populations and growing chronic disease prevalence increase routine blood draws. Over time the market progressed from simple metal needles to refined designs with flexible tubing, varied gauges and integrated safety shields, propelled by technological innovation and regulatory emphasis on needlestick prevention, with oncology clinics and pediatric wards exemplifying use.Building on that trajectory, the pivotal factor shaping the global butterfly needles market is regulatory pressure for safer devices combined with expanding outpatient and home-care testing, which together drive procurement. When hospitals and clinics respond to needlestick reduction mandates by specifying safety-shielded sets, manufacturers invest in ergonomic designs and automated shields, causing broader adoption and economies of scale that lower unit costs. In practice oncology infusion centers and mobile phlebotomy services adopt disposable winged sets to improve patient throughput and reduce occupational injuries, and as emerging markets upgrade labs, demand rises further creating opportunities for cost-competitive, environmentally friendlier product lines.
How is AI improving product design and safety in the Butterfly needles market?
AI is improving product design and safety in the butterfly needles market by shaping how devices are conceived tested and deployed. Designers use machine learning to analyze insertion forces vein anatomy and material behavior to refine bevel shape and tubing flexibility. AI also powers imaging guided placement and real time feedback that helps clinicians find fragile veins and avoid multiple sticks. In manufacturing AI driven visual inspection improves quality control and reduces defective units. The market is moving toward smarter safety features molded to clinical workflows and to products that are easier for clinicians to use and safer for patients and staff.Butterfly Network December 2023, announced a commercialization deal with Mendaera to combine its semiconductor ultrasound and AI imaging with robotic guidance for needle procedures which illustrates how AI enhanced visualization and automation can improve placement accuracy and support broader adoption of safer butterfly needle use.
Market snapshot - (2026-2033)
Global Market Size
USD 1.3 Billion
Largest Segment
Winged Butterfly Needles
Fastest Growth
Safety Butterfly Needles
Growth Rate
8.7% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global butterfly needles market is segmented by product type, application, end user, material type and region. Based on product type, the market is segmented into Winged Butterfly Needles and Safety Butterfly Needles. Based on application, the market is segmented into Intravenous Therapy and Blood Sampling. Based on end user, the market is segmented into Hospitals, Emergency Clinics and Home Healthcare. Based on material type, the market is segmented into Plastic and Glass. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Safety Butterfly Needles segment dominates because healthcare providers increasingly prioritize devices that minimize occupational hazards and comply with stringent safety regulations. Their engineered protective features and compatibility with institutional safety protocols drive adoption across clinical settings. Procurement decisions favor products that demonstrably lower exposure risk, prompting manufacturers to invest in safer designs and promoting widespread integration into standard venous access practices.
However, Winged Butterfly Needles are emerging as the most rapidly expanding area due to enduring clinician familiarity and ongoing product refinements that enhance usability for blood collection and delicate venous access. Improvements in tubing length, needle gauge options, and packaging convenience are broadening clinical use cases and creating new opportunities in outpatient diagnostics and procedural workflows.
Hospitals segment dominates because large clinical centers require reliable venous access products across multiple departments and purchase through centralized contracting. High patient throughput and complex procedures necessitate products that meet institutional safety, traceability, and supply continuity requirements. This drives steady institutional demand, encourages product standardization, and leads manufacturers to prioritize hospital-oriented features and regulatory compliance in their offerings.
However, Home Healthcare is emerging as the fastest growing area because expanding outpatient therapies and chronic care delivery outside institutional settings increase demand for simple, safe, and caregiver-friendly venous access solutions. Manufacturers are developing ready-to-use kits, patient education tools, and adaptable packaging to support decentralized care, opening new procurement channels and long-term adoption beyond traditional clinical environments.
To get detailed segments analysis, Request a Free Sample Report
North America dominates due to a mature healthcare ecosystem characterized by advanced clinical infrastructure, well established procurement channels, and high clinical adoption of safety and comfort oriented venipuncture devices. Strong presence of key manufacturers, concentrated R&D investment, and collaborative relationships between suppliers and large hospital systems accelerate product availability and innovation. Robust regulatory and quality frameworks support clinician confidence and product standardization, while training programs and outpatient diagnostic services drive consistent demand. Established reimbursement practices and high consumer awareness regarding minimally invasive blood collection further reinforce market leadership, enabling rapid integration of novel designs and a competitive landscape focused on reliability, supply chain resilience, and clinical convenience. Deep integration with diagnostic laboratories and home care providers sustains steady usage, while expansive distribution networks and engaged private payers facilitate market penetration.
Butterfly Needles Market in United States is shaped by concentrated clinical demand from hospitals and diagnostic centers, active manufacturer presence, and continuous product refinement focused on safety and user comfort. Close collaboration among suppliers, clinicians, and procurement teams accelerates adoption of enhanced designs. Broad availability through established distribution and specialized procurement channels supports diverse care settings, including outpatient and home care, reinforcing steady clinical preference for quality and convenience delivery.
Butterfly Needles Market in Canada reflects strong alignment between public health systems and medical suppliers, with emphasis on safe, patient friendly venipuncture solutions and clinician training. Regional procurement networks and distributor partnerships ensure reach into urban and remote care settings. Attention to product reliability and compatibility with diagnostic workflows supports uptake in hospital laboratories and community clinics. Ongoing collaboration with health authorities sustains focus on quality and standardized clinical practice.
Europe is experiencing rapid expansion driven by a combination of increasing diagnostic activity across varied care settings, harmonized regulatory frameworks that facilitate market entry, and a strong regional medtech manufacturing base that fosters product variety and quality. Clinician focus on patient comfort and occupational safety prompts adoption of specialized venipuncture solutions, while growth in private and outpatient diagnostic services broadens channels for distribution. Collaborative initiatives among hospitals, laboratories, and procurement organizations streamline large scale deployment, and localized innovation hubs support design adaptation for diverse clinical practices. Cross border distribution networks and public procurement mechanisms further enhance availability, positioning Europe as a dynamic market for both established and newer butterfly needle offerings. Heightened investment in clinician training and product customization for regional preferences, along with partnerships between device makers and specialty diagnostic providers, underpin deeper market penetration.
Butterfly Needles Market in Germany benefits from a concentrated medtech manufacturing base and a stringent regulatory culture that emphasizes product quality and clinical evidence. Hospital networks and research institutions collaborate with suppliers to refine device features and support clinician training. Public procurement practices and established distribution channels enable efficient reach into diverse care environments. A reputation for engineering excellence supports ongoing innovation. Strong ties with clinical stakeholders further accelerate adoption.
Butterfly Needles Market in United Kingdom is characterized by rapid adoption across private and public diagnostic channels, driven by a strong innovation ecosystem and active clinical evaluation. Emphasis on patient experience and occupational safety encourages uptake of comfortable, easy to use devices. Agile procurement approaches and partnerships between startups and established suppliers enable swift market introduction. Expansion of home sampling and community diagnostic services further broadens access and supports momentum.
Butterfly Needles Market in France is emerging through modernization of clinical services and growing emphasis on patient centered blood collection. Hospitals and private laboratories are increasingly evaluating devices that balance safety and ease of use, while regional procurement initiatives extend reach into varied care settings. Investment in clinician training supports acceptance. Collaboration among local and international suppliers aids adaptation of product features to meet national practice preferences and regulatory expectations.
Asia Pacific is strengthening its position through expanded clinical infrastructure, rising diagnostic capacity, and targeted investment in medical device manufacturing and adaptation. Local manufacturers and regional design centers tailor products to meet diverse clinical needs and price sensitivities, while collaborations with global suppliers accelerate technology transfer and market access. Growth of community diagnostic services and home collection initiatives increases demand for user friendly venipuncture solutions. Regulatory alignment and capacity building in training for clinicians and phlebotomists improve confidence in device performance. Enhanced distribution networks and strategic partnerships across countries support broader availability, enabling Asia Pacific to move from niche demand to a more prominent, innovation oriented market role. Emphasis on meeting international quality standards and local clinical research initiatives fosters clinician trust, while cost effective regional manufacturing and coordinated procurement efforts by hospital networks improve supply reliability and affordability.
Butterfly Needles Market in Japan is driven by an established medical device industry and a strong focus on product quality and clinical evidence. Hospitals and diagnostic centers favor refined designs that prioritize patient comfort and procedural efficiency. Active collaboration between domestic manufacturers and international technology partners supports innovation. Robust distribution networks and clinician training programs ensure consistent availability across hospital, laboratory and home care settings, reinforcing confidence of healthcare providers.
Butterfly Needles Market in South Korea reflects strong technology adoption and a proactive manufacturing sector that focuses on compact, user friendly designs. Hospitals, specialty clinics, and diagnostic laboratories engage in product evaluations that emphasize safety and ergonomic performance. Collaboration between device developers and clinical end users accelerates feature refinement, while export oriented manufacturers contribute to economies of scale. Distribution channels and training initiatives support adoption across broader community care settings.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Demand For Safer Procedures
Technological Advancements In Design
Regulatory Approval Complexity and Variability
Limited Reimbursement and Budget Pressure
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape in the global butterfly needles market is shaped by consolidation and rapid product innovation. Large strategic moves such as the ICU Medical acquisition of Smiths Medical and recent safety device clearances have intensified competition on safety and usability. Companies pursue acquisitions partnerships and targeted device innovation to win hospital and outpatient contracts while launching safety slide and pre attached holder designs as concrete examples.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global butterfly needles market is propelled primarily by rising demand for safer, minimally invasive, safety-engineered devices that reduce needlestick injuries and improve patient comfort, with technological advancements in design further enhancing usability and adoption. Growth is concentrated in North America, driven by mature healthcare infrastructure and strong procurement practices, while the Safety Butterfly Needles segment dominates as institutions prioritize engineered protective features. However regulatory approval complexity and variability remain a significant restraint, slowing product introductions and increasing costs for manufacturers, especially smaller players. The market will continue to evolve through innovation, home-care expansion, and sustainability-driven product redesigns.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.3 Billion |
| Market size value in 2033 | USD 2.75 Billion |
| Growth Rate | 8.7% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Butterfly Needles Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Butterfly Needles Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Butterfly Needles Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Butterfly Needles Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
